Primary hyperparathyroidism and the kidney: Biochemical and clinical spectrum

Journal of Bone and Mineral Research

Volumn 17, Issue SUPPL. 2, 2002, Pages

  Peacock, Munro ^a  

^a University of Hospital   (United States)

Author keywords

1,25 dihydroxyvitamin D; Calcium absorption; Calcium reabsorption; Hypercalcemia; Hypercalciuria; Hypophosphatemia; Nephrocalcinosis; Nephrolithiasis; Parathyroidectomy; Primary hyperparathyroidism; Serum calcium; Tubular reabsorption of calcium

Indexed keywords

CALCITRIOL; CALCIUM ION; PARATHYROID HORMONE; 1,25-DIHYDROXYVITAMIN D; BICARBONATE; CALCIUM; DRUG DERIVATIVE; PHOSPHATE; VITAMIN D;

CALCIUM ABSORPTION; CONFERENCE PAPER; HUMAN; HYPERCALCEMIA; KIDNEY CALCIFICATION; KIDNEY TUBULE ABSORPTION; NEPHROLITHIASIS; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; PRIMARY HYPERPARATHYROIDISM; VITAMIN D METABOLISM; GLOMERULUS FILTRATION RATE; HYPERPARATHYROIDISM; KIDNEY; KIDNEY DISEASE; KIDNEY FAILURE; METABOLISM; REVIEW; URINE;

BICARBONATES; CALCIUM; GLOMERULAR FILTRATION RATE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE; PHOSPHATES; VITAMIN D;

EID: 0036841832     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (54)

1. Robertson WG, Peacock M 1968 New techniques for the separation and measurement of the calcium fractions of normal human serum. Clin Chim Acta 20:315-326.
2. Peacock M 1998 Effects of calcium and vitamin D insufficiency on the skeleton. Osteopor Int Suppl 8:S45-S51.
3. Peacock M, Robertson WG, Nordin BEC 1969 Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet 1:384-386.
4. Nordin BEC, Peacock M 1969 Role of kidney in regulation of plasma calcium. Lancet 2:1280-1283.
5. Schipani E, Kruse K, Juppner H 1995 A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268:98-100.
6. 2+ sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303.
7. Pearce SHS, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115-1122.
8. Levine MA 1999 Pseudohypoparathyroidism: From bedside to bench and back. J Bone Miner Res 14:1255-1260.
9. Juppner H, Schipani E, Bastepe M 1998 The gene responsible for pseudohypoparathyroidism type 1b is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci USA 78:3098-3102.
10. Kidd GS, Schaff M, Adler RA 1980 Skeletal responsiveness in pseudohypoparathyroidism: A spectrum of clinical disease. Am J Med 68:772-781.
11. Friedman PA 2000 Renal calcium metabolism. In: Seldin DW, Giebisch G (eds.) The Kidney: Physiology and Pathophysiology. Lippincott Williams and Wilkins, Philadelphia, PA, USA, pp. 1751-1789.
12. Abou-Samra A-B, Jüppner H, Force T, Freeman MW, Kong X-F, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT Jr, Kronenberg HM, Segre GV 1992 Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblas-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 89:2732-2736.
13. 2+ -sensing receptor. Am J Kidney Dis 25:506-513.
14. 2+ -sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 271:F951-F956.
15. Peacock M 1988 Renal excretion of calcium. In: Nordin BEC (ed.) Calcium in Human Biology. Springer-Verlag, New York, NY, USA, pp. 125-169.
16. Lemann J Jr 1999 Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: A review. Nephron 81:18-25.
17. Suki WN, Yium JJ, von Minden M, Saller-Herbert C, Eknoyan G, Martinez-Maldonado M 1970 Acute treatment of hypercalcemia with frusemide. N Engl J Med 283:836-840.
18. Simon DB, Lifton RP 1996 The molecular basis of inherited hypokalemic alkalosis: Bartter's and Gitelman's syndrome. Am J Physiol 271:F961-F966.
19. Brickman AS, Massry SG, Coburn JW 1972 Changes in serum and urinary calcium during treatment with hydrochlorothiazide: Studies on mechanisms. J Clin Invest 51:945-954.
20. Peacock M, Nordin BEC 1968 Tubular reabsorption of calcium in normals and hypercalciuric subjects. J Clin Pathol 21:353-358.
21. Marshall DH, Peacock M, Nordin BEC 1972 Plasma calcium homeostasis. In: Hioco DJ (ed.) Rein et Calcium. Rueil-Malmaison, France, pp. 15-25.
22. Marshall DH 1976 Calcium and phosphate kinetics. In: Nordin BEC (ed.) Calcium, Phosphate, and Magnesium Metabolism. Churchill Livingstone, Edinburgh, UK, pp. 257-297.
23. Brunette MG, Chan M, Ferriere C 1978 Site of 1,25-(OH)2 vitamin D3 synthesis in the kidney. Nature 276:287-289.
24. Haussler MR, McCain TA 1977 Vitamin D metabolism and action. N Engl J Med 297:974-983.
25. Holick MF 1989 Vitamin D: Biosysnthesis, metabolism, and mode of action. In: DeGroot LJ (ed.) Endocrinology. WB Saunders Co., Philadelphia, PA, USA, pp. 902-926.
26. 2 vitamin D measured by radioimmunoassay and cytosol radio-receptor assay in normal subjects and patients with primary hyperparathyroidism and renal failure. Clin Chim Acta 101:93-101.
27. Slatopolsky E, Weerts C, Theilan J 1984 Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136-2143.
28. Francis RM, Peacock M, Barkworth SA 1984 Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 13:14-20.
29. Bulusu L, Hodgkinson A, Nordin BEC, Peacock M 1970 Urinary excretion of calcium and creatinine in relation to age and body weight in normal subjects and patients with renal calculi. Clin Sci 38:601-612.
30. Peacock M, Marshall RW, Robertson WG, Varnavides C, Nordin BEC 1976 Hypercalciuria and recurrent calcium stone disease: Effect of oral phosphate. In: Avioli L, Bordier PH, Fleisch H, Massry S, Slatopolsky E (eds.) Phosphate Metabolism, Kidney and Bone. Amour Montagu, Paris, France, pp. 63-78.
31. Peacock M, Marshall RW, Robertson WG, Varnavides C 1976 Renal stone disease in primary hyperparathyroidism and idiopathic stone-formers, etiology and treatment. In: Finlayson B, Thomas WC (eds.) Colloquium on Renal Lithiasis. University Press of Florida, Gainsville, FL, USA, pp. 101-111.
32. Peacock M 1975 Stone and bone disease in primary hyperparathyroidism and their relationship to the action of parathyroid hormone on calcium absorption. In: Talmage RV, Owen M (eds.) Calcium Regulating Hormones. Excerpta Medica, Amsterdam, The Netherlands, pp. 78-81.
33. Peacock M 1976 Parathyroid hormone and calcitonin. In: Nordin BEC (ed.) Calcium, Phosphate and Magnesium Metabolism. Churchill Livingstone, Edinburgh, UK, pp. 405-443.
34. Peacock M, Hodgkinson A, Nordin BEC 1967 Importance of dietary calcium in the definition of hypercalciuria. BMJ 3:469-471.
35. Bijvoet OLM, Morgan DB 1971 The tubular reabsorption of phosphate in man. In: Hioco DJ (ed.) Phosphate et Métabolisme Phosphocalcique. Sandoz 51, Paris, France, pp. 153-180.
36. Fan L, Wiederkehr MR, Collazo R, Wang H, Crowder LA, Moe OW 1999 Dual mechanisms of regulation of Na/H exchanger NHE-3 by parathyroid hormone in rat kidney. J Biol Chem 274:11289-11295.
37. Keating F 1961 Diagnosis of primary hyperparathyroidism. JAMA 178:547-555.
38. Cope O 1966 The story of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med 274:1174-1182.
39. Lloyd HM 1968 Primary hyperparathyroidism: An analysis of the role of the parathyroid tumor. Medicine 47:53-71.
40. Purnell DC, Smith LH, Scholz DA, Elveback LR, Arnaud CD 1971 Primary hyperparathyroidism: A prospective clinical study. Am J Med 50:670-678.
41. Hellstrom J, Ivemark BI 1962 Primary hyperparathyroidism, clinical and structural findings in 138 cases. Acta Chirurgica Scandinavica 294(Suppl):1-112.
42. McGeown MG 1965 Calcium and phosphorus metabolism in the diagnosis of hyperparathyroidism. Urol Int 19:83-92.
43. Yendt ER 1970 Renal calculi. Can Med Assoc J 102:479-489.
44. Lavan JN, Neale FC, Posen S 1971 Urinary calculi. Clinical, biochemical and radiological studies in 619 patients. Med J Aust 2:1049-1061.
45. Peacock M, Robertson WG 1989 Urinary calcium stone disease. In: DeGroot LJ, Besser GB, Cahill GF Jr, Marshall JC, Nelson DH, Odell WD, Potts JT Jr, Rubenstein AH, Steinberger E (eds.) Endocrinology. WB Saunders Co., Philadelphia, PA, USA, pp. 1111-1132.
46. Robertson WG, Peacock M, Nordin BEC 1971 Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin Sci 40:365-374.
47. Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB 1978 Risk factors in calcium stone disease of the urinary tract. Br J Urol 50:449-454.
48. Peacock M, Robertson WG, Marshall RW 1979 Disorders associated with recurrent calcium containing kidney stones. In: DeGroot LJ, Cahill GF, Martini L, Nelson DH, Odell WD, Potts JT, Steinberger E, Winegrad AI (eds.) Endocrinology 2. Grune & Stratton, New York, NY, USA, pp. 823-837.
49. Selby PL, Peacock M 1986 Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. N Engl J Med 314:1481-1485.
50. Shane E 1991 Medical management of asymptomatic primary hyperparathyroidism. J Bone Miner Res 6:S2;S131-S134.
51. Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S 2001 Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J Bone Miner Res 16:113-119.
52. Albright F, Baird PS, Cope O, Bloomberg E 1934 Studies on the physiology of the parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci 187:49-65.
53. Pyrah LN, Hodgkinson A 1960 Nephrocalcinosis. Br J Urol 11:361-373.
54. Anderson CK 1982 Pathology of nephrocalcinosis and stone formation. In: Chisholm GD, Williams DI (eds.) Urology. William Heinemann Medical Books Ltd., London, UK, pp. 296-301.